Pharmatek opens new facility
Pharmatek, a US pharmaceutical chemistry development organization supporting the drug industry, has announced the opening of its highly-potent and cytotoxic facility located in San Diego. The 18,000sqft plant includes newly-constructed analytical and formulation development laboratories and current Good Manufacturing Practice production suites dedicated to the development of highly-potent and cytotoxic drug product for early-phase clinical trials.
"Highly-potent and cytotoxic compounds are among the most sensitive drugs to handle and produce," said Kevin Rosenthal, director of manufacturing of Pharmatek.
The facility holds a State of California Food and Drug Branch Drug Manufacturers License and is currently working on a number of highly-potent development projects. The FDB license authorizes Pharmatek to manufacture and ship clinical material, the firm noted.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze